On December 28, the Sixth Greater Bay Area Biotechnology Innovation Competition awards ceremony for the Top 50 Innovative Biotechnology Enterprises was held with great fanfare in Nansha, Guangzhou. The event was organized by the China Innovation Industry Research Institute, hosted by Guangdong Medical Valley, and co-organized by Haitong Securities. Simultaneously, a Biotechnology Innovation Development Summit was held, aiming to bring together experts and investment professionals from the biopharmaceutical industry, discover outstanding players in the biotechnology sector, and explore collaborative innovation for industry development.

Shu Yuan, Dean of the China Innovation Industry Research Institute; Yan Zhen, Member of the Party Group and Deputy Director of the Guangdong Provincial Drug Administration; Sheng Nanfang, former Director of the China Southern Talent Market and former Vice President of the Guangdong Talent Exchange Association; Tan Hong, Chief Economist of the Guangzhou Development and Reform Commission; Xie Wei, Deputy Secretary of the Party Working Committee of Nansha Development Zone in Guangzhou; Wang Houhua, Deputy Director of the Guangdong Productivity Promotion Center; and Professor Lin Xinhua, Executive Dean of the Precision Medicine Research Institute of the Greater Bay Area, were among the experts who attended the ceremony.

After visits and screenings by the judging panel and investors, META successfully made it to the Top 50 Innovative Biotechnology Enterprises list in the Greater Bay Area and was awarded the title of Emerging Enterprise. This recognition reflects the high regard from numerous professionals for META’s achievements.